Immobilization of the soluble domain of human complement receptor 1 on agarose-encapsulated islets for the prevention of complement activation

Biomaterials

Volumn 31, Issue 34, 2010, Pages 8847-8853

  Luan, Nguyen Minh ^a   Teramura, Yuji ^b   Iwata, Hiroo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Agarose; Bioartificial pancreas; Immuno isolation; Islets of Langerhans; Microencapsulation; Soluble complement receptor 1 (sCR1)

Indexed keywords

AGAROSE; BIO-ARTIFICIAL PANCREAS; IMMUNO-ISOLATION; ISLETS OF LANGERHANS; MICROENCAPSULATION; SOLUBLE COMPLEMENT RECEPTOR 1 (SCR1);

BODY FLUIDS; PACKAGING;

INSULIN;

AGAROSE; COMPLEMENT COMPONENT C3B RECEPTOR; INSULIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOARTIFICIAL ORGAN; CELL CULTURE; CELL DAMAGE; CELL ENCAPSULATION; COMPLEMENT ACTIVATION; HEPATOCYTE TRANSPLANTATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; RAT; XENOGRAFT;

ANIMALS; CHO CELLS; COMPLEMENT ACTIVATION; CRICETINAE; CRICETULUS; GLUCOSE; HAPTENS; HUMANS; HYDROGEL; IMMOBILIZED PROTEINS; INSULIN; ISLETS OF LANGERHANS; LIPOSOMES; PROTEIN STRUCTURE, TERTIARY; RABBITS; RATS; RECEPTORS, COMPLEMENT; SEPHAROSE; SOLUBILITY; SULFHYDRYL COMPOUNDS;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 77957303282     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.08.004     Document Type: Article

References (33)

1. Hering B.J., Wijkstrom M., Graham M.L., Hårdstedt M., Aasheim T.C., Jie T., et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006, 12(3):301-303.
2. Miura S., Teramura Y., Iwata H. Encapsulation of islets with ultra-thin polyion complex membrane through poly(ethylene glycol)-phospholipids anchored to cell membrane. Biomaterials 2006, 27:5828-5835.
3. Iwata H., Takagi T., Shimizu H., Yamashita K., Kobayashi K., Akutsu T. Agarose for bioartificial pancreas. J Biomed Mater Res 1992, 26:967-977.
4. Lacy P.E., Hegre O.D., Gerasimidi-Vazeou A., Gentile F.T., Dionne K.E. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 1991, 254:1782-1784.
5. Lanza R.P., Butler D.H., Borland K.M., Staruk J.E., Faustman D.L., Solomon B.A., et al. Xenotransplanation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci USA 1991, 88:11100-11104.
6. Lanza R.P., Sullivan S.J., Chick W.L. Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 1992, 41:886-889.
7. Teramura Y., Iwata H. Islet encapsulation with living cells for improvement of biocompatibility. Biomaterials 2009, 30:2270-2275.
8. Teramura Y., LuanNM Iwata H. Microencapsulation of islets with living cells using PolyDNA-PEG-lipid conjugate. Bioconjug Chem 2009, 21(4):792-796.
9. Iwata H., Kobayashi K., Takagi T., Oka T., Yang H., Amemiya H., et al. Feasibility of agarose microbeads with xenogeneic islets as a bioartificial pancreas. J Biomed Mater Res 1994, 28:1003-1011.
10. Kin T., Iwata H., Aomatsu Y., Ohyama T., Kanehiro H., Hisanaga M., et al. Xenotransplantation of pig islets in diabetic dogs with use of a microcapsule composed of agarose and polystyrene sulfonic acid mixed gel. Pancreas 2002, 25:94-100.
11. Kobayashi T., Aomatsu Y., Iwata H. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosupression. Transplantation 2003, 75:619-625.
12. Aomatsu Y., Nakajima Y., Iwata H., Amemiya H., Kanehiro H., Hisanaga M., et al. Significance of low doses of 15-deoxyspergualin in agarose-microencapsulated discordant islet xenotransplantation. Transpl Proc 1995, 27:292-293.
13. Mulligan M.S., Yeh C.G., Rudolph A.R., Ward P.A. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury. J Immunol 1991, 148:1479-1485.
14. Swift A.J., Collins T.S., Bugelski P., Winkelstein J.A. Soluble human complement receptor type 1 inhibits complement-mediated host defense. Clin Diagn Lab Immunol 1994, 1(5):585-589.
15. Ryan U.S. Complement inhibitory therapeutics and xenotransplantation. Nat Med 1995, 1(9):967-968.
16. Weisman H.F., Bartow T., Leppo M.K., Marsh H.C., Carson G.R., Concido M.F., et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post ischemic myocardial inflammation and necrosis. Science 1990, 249:146-151.
17. Pratt J.R., Hibbs M.J., Laver A.J., Smith R.A., Sacks S.H. Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. Am J Pathol 1996, 149(6):2055-2066.
18. Pruitt S.K., Kirk A.D., Bollinger R.R., Marsh H.C., Collins B.H., Levin J.L., et al. The effect of soluble complement receptor 1 on hyperacute rejection of porcine xenografts. Transplantation 1994, 57:363-370.
19. Bennet W., Sundberg B., Lundgren T., Tibell A., Groth C.G., Richards A., et al. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation 2000, 69:711-719.
20. Candinas D., Lesnikoski B.A., Robson S.C., Miyatake T., Scesney S.M., Marsh H.C., et al. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. Transplantation 1996, 62:336-342.
21. Kato H., Inoue T., Ishii N., Murakami Y., Matsumura M., Seya T., et al. Novel simple method to purify recombinant soluble human complement receptor type 1 (sCR1) from CHO cell culture. Biotechnol Bioprocess Eng 2002, 7:67-75.
22. Yamamoto S., Kubotsu K., Kida M., Kondo K., Matsuura S., Uchiyama S., et al. Automated homogeneous liposome-based assay system for total complement activity. Clin Chem 1995, 41:586-590.
23. Lacy P.E., Kostianovky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967, 16:35-39.
24. Bretzel R.G., Hering B.J., Federlin K.F. Assessment of adult islet preparations. Methods in cell transplantation 1995, 455-464. RG Landes, Austin, TX. C. Ricordi (Ed.).
25. Bach F.H., Platt J.L., Cooper D.K.C. Accommodation - the role of natural antibody and complement in discordant xenograft rejection. Xenotransplantation. The transplantation of organs and tissues between species 1991, 81-99. Springer, New York. D.K.C. Cooper, E. Kemp, K. Reemtsma, D.J.G. White (Eds.).
26. Zhang Z., Bédard E., Luo Y., Wang H., Deng S., Kelvin D., et al. Animal models in xenotransplantation. Expert Opin Investig Drugs 2000, 9:2051-2068.
27. Engberg A.E., Sandholm K., Bexborn F., Persson J., Nilsson B., Lindahl G., et al. Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptides. Biomaterials 2009, 30:2653-2659.
28. Rydgren T., Bengtsson D., Sandler S. Complete protection against Interleukin-1β-induced functional suppression and cytokine-mediated cytotoxicity in rat pancreatic islets in vitro using an Interleukin-1 cytokine trap. Diabetes 2006, 55:1407-1412.
29. Kim D.H., Smith J.T., Chilkoti A., Reichert W.M. The effect of covalently immobilized rhIL-1ra-ELP fusion protein on the inflammatory profile of LPS-stimulated human monocytes. Biomaterials 2007, 28(23):3369-3377.
30. Cabric S., Sanchez J., Johansson U., Larsson R., Nilsson B., Korsgren O., et al. Anchoring of vascular endothelial growth factor to surface-immobilized heparin on pancreatic islets: implications for stimulating islet angiogenesis. Tissue Eng Part A 2010, 16(3):961-970.
31. Su J., Hu B.H., Lowe W.L., Kaufman D.B., Messersmith P.B. Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation. Biomaterials 2010, 31(2):308-314.
32. Cheung C.Y., Anseth K.S. Synthesis of immunoisolation barriers that provide localized immunosuppression for encapsulated pancreatic islets. Bioconjug Chem 2006, 17:1036-1042.
33. Lam T.T., Hausen B., Hook L., Lau M., Higgins J., Christians U., et al. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts. Xenotransplantation 2005, 12:20-29.